tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RCUS Stock Latest News

Arcus Biosciences’ AB598 Study: A New Frontier in Cancer Treatment
Company AnnouncementsArcus Biosciences’ AB598 Study: A New Frontier in Cancer Treatment
2d ago
RCUS
Gilead and Arcus Advance Promising Colorectal Cancer Study
PremiumCompany Announcements
Gilead and Arcus Advance Promising Colorectal Cancer Study
2d ago
GILD
RCUS
Gilead and Arcus Advance Phase 2 Study in Lung Cancer Immunotherapy
PremiumCompany Announcements
Gilead and Arcus Advance Phase 2 Study in Lung Cancer Immunotherapy
2d ago
GILD
RCUS
Arcus Biosciences’ AB801 Study: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Arcus Biosciences’ AB801 Study: A Potential Game-Changer in Cancer Treatment
2d ago
RCUS
Arcus Biosciences’ AB680 Study: A New Hope for Pancreatic Cancer Treatment?
PremiumCompany Announcements
Arcus Biosciences’ AB680 Study: A New Hope for Pancreatic Cancer Treatment?
2d ago
RCUS
Gilead and Arcus Biosciences’ Promising Phase 2 Study Update in Gastrointestinal Cancer
PremiumCompany AnnouncementsGilead and Arcus Biosciences’ Promising Phase 2 Study Update in Gastrointestinal Cancer
2d ago
GILD
RCUS
AstraZeneca’s Promising Phase III Study on Lung Cancer Treatment
Premium
Company Announcements
AstraZeneca’s Promising Phase III Study on Lung Cancer Treatment
3d ago
AZN
RCUS
Arcus Biosciences’ Promising Phase 3 Trial: A Potential Game-Changer in Pancreatic Cancer Treatment
Premium
Company Announcements
Arcus Biosciences’ Promising Phase 3 Trial: A Potential Game-Changer in Pancreatic Cancer Treatment
3d ago
RCUS
Gilead and Arcus Biosciences’ Promising Phase 3 Cancer Trial Update
PremiumCompany Announcements
Gilead and Arcus Biosciences’ Promising Phase 3 Cancer Trial Update
3d ago
GILD
RCUS
AstraZeneca’s Promising Phase III Study on NSCLC: What Investors Need to Know
PremiumCompany Announcements
AstraZeneca’s Promising Phase III Study on NSCLC: What Investors Need to Know
5d ago
AZN
RCUS
Arcus Biosciences Holds Annual Stockholders Meeting
PremiumCompany Announcements
Arcus Biosciences Holds Annual Stockholders Meeting
17d ago
8K
RCUS
Promising Efficacy and Safety of Arcus Biosciences’ Combination Therapy Reinforces Buy Rating
PremiumRatings
Promising Efficacy and Safety of Arcus Biosciences’ Combination Therapy Reinforces Buy Rating
27d ago
RCUS
Arcus Biosciences Presents Promising Phase 1/1b Trial Data
PremiumCompany AnnouncementsArcus Biosciences Presents Promising Phase 1/1b Trial Data
28d ago
8K
RCUS
Arcus Biosciences: Promising Results Amidst Uncertainty and Safety Concerns
Premium
Ratings
Arcus Biosciences: Promising Results Amidst Uncertainty and Safety Concerns
28d ago
RCUS
Arcus Biosciences presented data for casdatifan plus cabozantinib
Premium
The Fly
Arcus Biosciences presented data for casdatifan plus cabozantinib
28d ago
RCUS
Arcus Biosciences’ Earnings Call: Strategic Gains Amid Revenue Challenges
PremiumCompany Announcements
Arcus Biosciences’ Earnings Call: Strategic Gains Amid Revenue Challenges
2M ago
RCUS
Arcus Biosciences price target lowered to $26 from $29 at Wells Fargo
PremiumThe Fly
Arcus Biosciences price target lowered to $26 from $29 at Wells Fargo
2M ago
RCUS
Promising Potential of Arcus Biosciences’ ARC-20 Trial Drives Buy Rating
PremiumRatings
Promising Potential of Arcus Biosciences’ ARC-20 Trial Drives Buy Rating
2M ago
RCUS
Arcus Biosciences: Promising Pipeline and Financial Health Justify Buy Rating
PremiumRatings
Arcus Biosciences: Promising Pipeline and Financial Health Justify Buy Rating
2M ago
RCUS
Arcus Biosciences Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsArcus Biosciences Reports Q1 2025 Financial Results
2M ago
RCUS
Arcus Biosciences reports Q1 EPS ($1.14), consensus ($1.01)
Premium
The Fly
Arcus Biosciences reports Q1 EPS ($1.14), consensus ($1.01)
2M ago
RCUS
RCUS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RCUS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
RCUS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >